Evidence map›Paper›PMID 34095774›Full record

ArticleACS applied nano materials2021

Water-Soluble Noble Metal Nanoparticle Catalysts Capped with Small Organic Molecules for Organic Transformations in Water.

Al-Mahmnur Alam, Young-Seok Shon

Abstract read
In one paragraph

Article in ACS applied nano materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Water-Dispersible Ruthenium Nanocatalyst for Carbonyl Reduction With DAngewandte Chemie (International ed. in English) · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Al-Mahmnur AlamDepartment of Chemistry and Biochemistry and the Keck Energy and Materials Program (KEMP), California State University, Long Beach, Long Beach, California 90840, United States.
Young-Seok ShonDepartment of Chemistry and Biochemistry and the Keck Energy and Materials Program (KEMP), California State University, Long Beach, Long Beach, California 90840, United States.ORCID 0000-0003-4765-6130

Funding

Synthesis of Gold Nanoparticle-Cored Dendrimers Linked with Fluorophores and AntiSC3GM089562 · NIGMS · CALIFORNIA STATE UNIVERSITY LONG BEACH · PI SHON, YOUNG · 2011 to 2019
$859k
NIGMS NIH HHS SC3 GM089562
6 · The paper itself

Abstract

This article recaps a variety of interesting catalytic studies based on solubilized and freely movable noble metal nanoparticle catalysts employed for organic reactions in either pure water or water-organic biphasic systems. Small organic ligand-capped metal nanoparticles are fundamentally attractive materials due to their enormous potential as a well-defined system that can provide spatial control near active catalytic sites. The nanoparticle catalysts are first grouped based on the synthetic method (direct reduction, phase transfer, and redispersion) and then again based on the type of reaction such as alkene hydrogenation, arene hydrogenation, nitroaromatic reduction, carbon-carbon coupling reactions, etc. The impacts of various ligands on the catalytic activity and selectivity of semi-heterogeneous nanoparticles in water are discussed in detail. The catalytic systems using polymers, dendrimers, and ionic liquids as supporting or protecting materials are excluded from the subject of this review.

Indexed as

biphasic catalysiscatalysiscoupling reactiongreen catalysishydrogenationnanoparticlenoble metalsemi-heterogeneous

Identifiers

PMID34095774
PMCPMC8171274

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.